Diagnosis and treatment of hepatocellular carcinoma.

By Hashem B El, Serag, Jorge A. Marrero, L. Rudolph, K. R. Reddy. Gastroenterology, 2008

1,475 citations recorded by the source corpus.

Subfields: Cancer Research, Epidemiology, Hepatology

View Paper: https://www.semanticscholar.org/paper/cb6e281111d8435885fce95cbc34c77b35c015df

How researchers see this paper

The researchers whose trusted networks rank it highest, strongest advocate first. Every researcher gets a different order.

In Epidemiology

1. J. Llovet
2. Jordi Bruix1 , 2
3. Alejandro Forner1 , 2
4. M. Kudo
5. María E. Reig1 , 2
6. K. McGlynn
7. H. B. EL‐SERAG
8. M. Sherman

In Hepatology

1. J. Llovet
2. Jordi Bruix1 , 2
3. Alejandro Forner1 , 2
4. María E. Reig1 , 2
5. M. Kudo
6. Carlos Rodriguez de Lope1
7. A. Cheng
8. K. McGlynn

Citations in the corpus

• Hepatocellular carcinoma incidence, mortality, and survival trends in the United States from 1975 to 2005. (2009, background): “Tertiary measures for HCC vary by stage of disease and comorbidity but include surgical resection, transplantation, radiofrequency ablation, and chemoembolization.(28) A SEER-Medicare linked study of HCC patients diagnosed in the 1990s indicated that only one third of cases with favorable tumor feat”
• Alpha-fetoprotein, Des-gamma Carboxyprothrombin, and Lectin-Bound Alpha-fetoprotein in Early Hepatocellular Carcinoma (2009, background): “C=Caucasian, AA=African American, As=Asian.”
• Current Strategy for Staging and Treatment: The BCLC Update and Future Prospects (2010, background): “It is also worth stressing that the management and treatment of patients with HCC should be done in expert settings where all the knowledge and skills related to the specialities involved is readily available.(33) Only if this partnership is in place will optimal care be delivered with state of the ”
• Asia–Pacific clinical practice guidelines on the management of hepatocellular carcinoma: a 2017 update (2017, background): “In addition, TACE can be performed in patients at early stage in whom RFA is difficult to perform because of tumor location or medical comorbidities [516].”
• Asian Pacific Association for the Study of the Liver consensus recommendations on hepatocellular carcinoma (2010, background): “S. K. Sarin Department of Gastroenterology, G. B. Pant Hospital, University of Delhi, New Delhi, India Geographical distribution The prevalence of HCC worldwide parallels that of viral hepatitis, and the majority of cases are associated with HBV and HCV. Chronic HBV infection is a leading cause of H”